| CTRI Number |
CTRI/2025/09/094339 [Registered on: 08/09/2025] Trial Registered Prospectively |
| Last Modified On: |
05/09/2025 |
| Post Graduate Thesis |
Yes |
| Type of Trial |
Interventional |
|
Type of Study
|
Dentistry |
| Study Design |
Other |
|
Public Title of Study
|
Effect of Salmon Calcitonin Nasal Spray on Bone Healing After Wisdom Tooth Removal |
|
Scientific Title of Study
|
Evaluation of the Efficacy of Intranasal Salmon Calcitonin on Bone Healing Following Surgical Removal of Impacted Mandibular Third Molars — A Randomized Controlled Clinical Trial |
| Trial Acronym |
NIL |
|
Secondary IDs if Any
|
| Secondary ID |
Identifier |
| NIL |
NIL |
|
|
Details of Principal Investigator or overall Trial Coordinator (multi-center study)
|
| Name |
Harni N |
| Designation |
Post Graduate |
| Affiliation |
Madha Dental College |
| Address |
Somangalam Main Rd, Madha Nagar, Kundrathur, Chennai, Sikkarayapuram, Tamil Nadu 600069 Somangalam Main Rd, Madha Nagar, Kundrathur, Chennai, Sikkarayapuram, Tamil Nadu 600069 Chennai TAMIL NADU 600030 India |
| Phone |
9791048562 |
| Fax |
|
| Email |
n.harni001@gmail.com |
|
Details of Contact Person Scientific Query
|
| Name |
Dr. Satheesh C |
| Designation |
Professor |
| Affiliation |
Madha Dental College |
| Address |
Somangalam Main Rd, Madha Nagar, Kundrathur, Chennai, Sikkarayapuram, Tamil Nadu 600069 Somangalam Main Rd, Madha Nagar, Kundrathur, Chennai, Sikkarayapuram, Tamil Nadu 600069 Chennai TAMIL NADU 600030 India |
| Phone |
9791048562 |
| Fax |
9791048562 |
| Email |
ch.satheesh@gmail.com |
|
Details of Contact Person Public Query
|
| Name |
Harni N |
| Designation |
Post Graduate |
| Affiliation |
Madha Dental College |
| Address |
Somangalam Main Rd, Madha Nagar, Kundrathur, Chennai, Sikkarayapuram, Tamil Nadu 600069 Somangalam Main Rd, Madha Nagar, Kundrathur, Chennai, Sikkarayapuram, Tamil Nadu 600069 Chennai TAMIL NADU 600030 India |
| Phone |
9791048562 |
| Fax |
|
| Email |
n.harni001@gmail.com |
|
|
Source of Monetary or Material Support
|
|
|
Primary Sponsor
|
| Name |
Harni N |
| Address |
Somangalam Main Rd, Madha Nagar, Kundrathur, Chennai, Sikkarayapuram, Tamil Nadu 600069 |
| Type of Sponsor |
Other [Dental College] |
|
|
Details of Secondary Sponsor
|
|
|
Countries of Recruitment
|
India |
|
Sites of Study
|
| No of Sites = 1 |
| Name of Principal
Investigator |
Name of Site |
Site Address |
Phone/Fax/Email |
| Dr Harni N |
Madha Dental College |
Somangalam Main Rd, Madha Nagar, Kundrathur, Chennai, Sikkarayapuram, Tamil Nadu 600069 Chennai TAMIL NADU |
7273901234
n.harni001@gmail.com |
|
|
Details of Ethics Committee
|
| No of Ethics Committees= 1 |
| Name of Committee |
Approval Status |
| Ethical committee clearance madha dental college and hospital |
Approved |
|
|
Regulatory Clearance Status from DCGI
|
|
|
Health Condition / Problems Studied
|
| Health Type |
Condition |
| Patients |
(1) ICD-10 Condition: K011||Impacted teeth, |
|
|
Intervention / Comparator Agent
|
| Type |
Name |
Details |
| Intervention |
Calcitonin Nasal Spray |
Observing bone healing and analgesic effect of calcitonin hormone after third molar removal surgery for a total period of three months. |
| Comparator Agent |
Comparing with normal bone healing. |
Comparing with normal bone healing after third molar removal surgery. |
|
|
Inclusion Criteria
|
| Age From |
18.00 Year(s) |
| Age To |
40.00 Year(s) |
| Gender |
Both |
| Details |
Patients with impacted mandibular third molar.
Pederson difficulty index score of 6 and above.
Patients in the age group between 18 to 40 years
ASA-1 category
|
|
| ExclusionCriteria |
| Details |
Patients with seafood alleregy
Patients with Peri apical pathology
ASA-2,3,4,5 and 6 CATEGORIES
Patient with any previous history of cardiomyopathy
Patient with any known history of Thyroid dysfunction.
Patient undergoing therapies with bisphosphonates and immunosuppressants.
Patient with any known history of osteoporosis or pathologic fractures.
Asthmatic patients.
|
|
|
Method of Generating Random Sequence
|
|
|
Method of Concealment
|
|
|
Blinding/Masking
|
|
|
Primary Outcome
|
| Outcome |
TimePoints |
| A total of 100 patients will be randomly divided into two groups: Group I will receive intranasal salmon calcitonin along with standard postoperative care, while Group II will receive only standard care. |
Postoperative pain will be assessed using the Visual Analog Scale on days 1, 7, 14, 21, and 30. |
|
|
Secondary Outcome
|
| Outcome |
TimePoints |
| bone healing will be evaluated by radiographic assessment of bone density at the extraction site immediately after surgery. |
Assessed at 4 weeks, and at 12 weeks. |
|
|
Target Sample Size
|
Total Sample Size="100" Sample Size from India="100"
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" |
|
Phase of Trial
|
Phase 3 |
|
Date of First Enrollment (India)
|
20/09/2025 |
| Date of Study Completion (India) |
Applicable only for Completed/Terminated trials |
| Date of First Enrollment (Global) |
Date Missing |
| Date of Study Completion (Global) |
Applicable only for Completed/Terminated trials |
|
Estimated Duration of Trial
|
Years="2" Months="6" Days="0" |
|
Recruitment Status of Trial (Global)
|
Not Applicable |
| Recruitment Status of Trial (India) |
Not Yet Recruiting |
|
Publication Details
|
N/A |
|
Individual Participant Data (IPD) Sharing Statement
|
Will individual participant data (IPD) be shared publicly (including data dictionaries)?
Response - NO
|
|
Brief Summary
|
This randomized controlled study will evaluate the efficacy of salmon calcitonin nasal spray on bone healing and postoperative pain following surgical removal of impacted third molar. A total of 100 patients will be randomly divided into two groups : Group 1 will receive intranasal salmon calcitonin along with standard postoperative care, while group 2 will receive standard care. Post op pain will be assessed using Visual Analogue Scale VAS on day 1,7,14,21 and 30, and bone healing will be evaluated by radiographic assessment of bone density at extraction site immediately after surgery, at 4 weeks and 12 weeks. |